Recent news that Robin Williams had suffered from the early stages of Parkinson’s Disease preceding his death has been quite a surprise to many. Other celebrities have suffered from the effects of this dangerous disease for many years: Muhammad Ali, Johnny Cash, and Michael J. Fox. From these big names, has come widespread media attention, and awareness. This week, a big step has been taken towards finding new data to control the effects of Parkinson’s.
Intel announced on Wednesday its plans to use wearable gadgets such as smart watches to monitor patients with Parkinson’s disease and collect data that can be shared with researchers.
The well-known chip maker said that it is teaming up with the Michael J. Fox Foundation, established by the actor and Parkinson’s sufferer in 2000, to conduct a multi-phase research study of the neurodegenerative brain disease. An estimated five million people globally have been diagnosed with Parkinson’s, the second-most-common neurodegenerative disease after Alzheimer’s.
Their initial goal is to determine the feasibility of using wearable devices to monitor patients remotely and store that data in an open system that can be accessed by scientists.
The next phase of the study, which has been said will likely kick off in the fall, the foundation plans to set aside funds to explore how patients are responding to medication. Participants will be monitored via an array of wearable devices.
Clinical trials have been said to be far too “subjective” in the past. For instance, a patient might inform her doctor that she felt a tremor for several minutes, when it actually lasted a matter of seconds. In the future, Intel hopes patients and their doctors will have more precise measurements via wearable devices about the “frequency and severity” of symptoms.
The Michael J. Fox foundation will continue to raise funding to cover the costs of providing wearable devices to patients.
By using such devices, the foundation and other research groups can tap into a broader pool of patients for clinical trials. Today, many people with Parkinson’s disease are unable to participate in clinical trials because they do not live near a research facility. However, wearable devices offer a convenient way to track patients from their work or homes, allowing people in the most rural parts of the country to participate.
As the technology expands beyond the Parkinson’s Research, Intel hopes to capture a share of the growing market for big data analytics and wearable devices in the health sector.
While Intel boasts its own wearable technologies, Intel stressed that the Parkinson’s study is device agnostic, meaning patients can test a variety of wearable gadgets. In March, Intel completed its acquisition of Basis Science, a startup that is best known for its wrist-band that measures the wearer’s heart rate.